[One case of type 1 auto-immune polyendocrinopathy or APECED].

[1]  J. Perheentupa.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. , 2006, The Journal of clinical endocrinology and metabolism.

[2]  A. Irvine,et al.  Dermatological manifestations of autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy syndrome , 2006, The British journal of dermatology.

[3]  M. Manns,et al.  Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. , 2004, The Journal of clinical endocrinology and metabolism.

[4]  J. Perheentupa.  APS-I/APECED: the clinical disease and therapy. , 2002, Endocrinology and metabolism clinics of North America.

[5]  L. Peltonen,et al.  AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. , 2002, The Journal of clinical endocrinology and metabolism.

[6]  P. Nenoff,et al.  Autoimmune polyglandular syndrome (APS) type 1 and candida onychomycosis. , 2002, European journal of dermatology : EJD.

[7]  S. Antonarakis,et al.  APECED mutations in the autoimmune regulator (AIRE) gene , 2001, Human mutation.

[8]  M. Halonen,et al.  Autoimmune polyendocrine syndrome type 1 (APS I) in Norway , 2001, Clinical endocrinology.

[9]  L. Peltonen,et al.  Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. , 2000, American journal of human genetics.

[10]  J. Haavik,et al.  Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. , 2000, Biochemical and biophysical research communications.

[11]  S. Marsigliante,et al.  Assessment of enamel hypoplasia in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[12]  C. Betterle,et al.  Autoimmune polyglandular syndrome type 1 , 1998 .

[13]  Shinsei Minoshima,et al.  Positional cloning of the APECED gene , 1997, Nature Genetics.

[14]  T. Tuomi,et al.  Autoantibodies against Aromatic L-amino Acid Decarboxylase in Autoimmune Polyendocrine Syndrome Type I* Subjects and Methods Subjects , 2022 .

[15]  P. Lukinmaa,et al.  Microanatomy of the dental enamel in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED): report of three cases. , 1996, Journal of craniofacial genetics and developmental biology.

[16]  C. Ditre,et al.  Candidiasis endocrinopathy syndrome. Treatment with itraconazole. , 1994, Archives of dermatology.

[17]  J. Perheentupa,et al.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. , 1990, The New England journal of medicine.

[18]  D. Doniach,et al.  Antibodies to melanocytes in vitiligo. , 1984, Lancet.

[19]  J. Nordlund,et al.  Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis. , 1981, Archives of dermatology.

[20]  N. Maclaren,et al.  Two Types of Autoimmune Addison's Disease Associated with Different Polyglandular Autoimmune (PGA) Syndromes , 1981, Medicine.

[21]  M. Leonard,et al.  Chronic idiopathic hypoparathyroidism with superimposed Addison's disease in a child. , 1946, The Journal of clinical endocrinology and metabolism.

[22]  E. Thorpe,et al.  CHRONIC TETANY AND CHRONIC MYCELIAL STOMATITIS IN A CHILD AGED FOUR AND ONE-HALF YEARS , 1929 .